STK17B Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant STK17B.
|Application ||WB, IHC, IF, E|
|Calculated MW||42344 Da|
|Other Names||Serine/threonine-protein kinase 17B, DAP kinase-related apoptosis-inducing protein kinase 2, STK17B, DRAK2|
|Target/Specificity||STK17B (AAH16040, 272 a.a. ~ 372 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||STK17B Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Rose JE, et al. Mol Med, 2010 Jul-Aug. PMID 20379614.The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. Landa I, et al. PLoS Genet, 2009 Sep. PMID 19730683.Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer. Doherty GA, et al. Br J Cancer, 2009 Aug 4. PMID 19638987.Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development. Gatzka M, et al. J Immunol, 2009 Jul 1. PMID 19542440.Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes. Friedrich ML, et al. J Biol Chem, 2007 Feb 16. PMID 17182616.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.